( NASDAQ-NMS:CADX )

News from cadence pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Feb 28, 2014, 16:00 ET Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results

 Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing...


Jan 13, 2014, 08:30 ET Cadence Pharmaceuticals Estimates Fourth Quarter and Full Year 2013 Product Revenue and Provides Full Year 2014 Revenue Guidance

 Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing...


Dec 09, 2013, 09:00 ET New Data Detailing Economic Impact of IV Acetaminophen in Treating Acute Pain to be Presented at Two Major Healthcare Conferences

Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing...


Nov 26, 2013, 16:00 ET Cadence Pharmaceuticals' CEO Ted Schroeder To Present At The 25th Annual Piper Jaffray Healthcare Conference On December 4, 2013

Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing...


Nov 14, 2013, 18:54 ET Cadence Pharmaceuticals Reports Positive Outcome In OFIRMEV® Patent Litigation

 Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing...


Nov 08, 2013, 15:00 ET Cadence Pharmaceuticals Recognized As A Top Workplace In San Diego Based On Employee Feedback

Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing...


Nov 05, 2013, 16:00 ET Cadence Pharmaceuticals Reports Third Quarter 2013 Financial Results

 Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing...


Oct 29, 2013, 16:00 ET Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Third Quarter 2013 Financial Results On November 5, 2013

Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing...


Sep 04, 2013, 16:00 ET Cadence Pharmaceuticals' CEO Ted Schroeder To Present At The Stifel Nicolaus Healthcare Conference 2013 On September 11, 2013

Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary...


Aug 15, 2013, 17:17 ET Cadence Pharmaceuticals Comments on USPTO's Non-Final, Initial Office Action on Reexamination of Patent

Cadence Pharmaceuticals, Inc. (Nasdaq: CADX) today announced that the United States Patent and Trademark Office (USPTO), has issued a non-final,...


Aug 15, 2013, 08:30 ET Cadence Pharmaceuticals Appoints Laureen DeBuono to its Board of Directors

 Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing...


Aug 06, 2013, 17:45 ET Cadence Pharmaceuticals To Present At The 2013 Wedbush PacGrow Life Sciences Management Access Conference On August 13, 2013

 Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing...


Jul 31, 2013, 16:00 ET Cadence Pharmaceuticals Reports Second Quarter 2013 Financial Results

 Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and...


Jul 24, 2013, 16:00 ET Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Second Quarter 2013 Financial Results On July 31, 2013

 Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing...


Jul 02, 2013, 18:00 ET Cadence Pharmaceuticals To Present At The 8th Annual JMP Securities Healthcare Conference On July 9, 2013

Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary...


May 08, 2013, 16:00 ET Cadence Pharmaceuticals To Present At Three Investment Conferences During The Month Of May 2013

 Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing...


May 02, 2013, 16:00 ET Cadence Pharmaceuticals Reports First Quarter 2013 Financial Results

 Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing...


Apr 25, 2013, 16:00 ET Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss First Quarter 2013 Financial Results On May 2, 2013

Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing...


Mar 14, 2013, 16:00 ET Cadence Pharmaceuticals Appoints Stephen L. Newman, M.D., to its Board of Directors

Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing...


Mar 12, 2013, 08:00 ET Cadence Pharmaceuticals Announces the Availability of OFIRMEV® (acetaminophen) Injection through the VA National Formulary

 Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), announced today that the Department of Veterans Affairs has made OFIRMEV® (acetaminophen)...


Mar 07, 2013, 07:30 ET Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2012 Financial Results

 Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing...


Mar 06, 2013, 20:23 ET Cadence Pharmaceuticals Announces Strategic Plan to Secure Long-Term Manufacture and Supply of OFIRMEV® (acetaminophen) Injection

 Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing...


Feb 28, 2013, 16:15 ET Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Fourth Quarter And Full Year 2012 Financial Results On March 7, 2013

Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing...


Feb 26, 2013, 16:00 ET Cadence Pharmaceuticals' CEO Ted Schroeder To Present At The Cowen & Company 33rd Annual Health Care Conference In Boston On March 5, 2013

 Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and...


Feb 06, 2013, 17:32 ET Cadence Pharmaceuticals' CEO Ted Schroeder To Present At The Leerink Swann Global Healthcare Conference In New York City On February 13, 2013

Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing...